Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Should GlaxoSmithKline Have Accepted Unilever's $68 Billion Consumer Health Offer?
Should GlaxoSmithKline Have Accepted Unilever's $68 Billion Consumer Health Offer?
Should GlaxoSmithKline Have Accepted Unilever's $68 Billion Consumer Health Offer?
Submitted by
admin
on January 28, 2022 - 10:20am
Source:
Motley Fool
News Tags:
GSK
Unilever
M&A
consumer health
Headline:
Should GlaxoSmithKline Have Accepted Unilever's $68 Billion Consumer Health Offer?
snippet:
Unilever offered $68 billion to buy the combined consumer health unit of GSK and Pfizer.
GSK turned down the offer for the joint venture and still plans to spin off the consumer health unit.
Do Not Allow Advertisers to Use My Personal information
